VRK1 Antibodies

Santa Cruz Biotechnology provides a broad selection of VRK1 monoclonal antibodies for research focused on understanding Vaccinia-related kinase 1 (VRK1). VRK1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VRK1 is a serine/threonine kinase that plays a crucial role in cell cycle regulation, DNA damage response, and transcriptional control. The involvement of VRK1 in cellular processes makes it an important target for studying cancer and other diseases where cell proliferation and survival are affected. Understanding VRK1 function can provide insights into therapeutic strategies for various conditions. VRK1 monoclonal antibodies enable detailed analysis of protein expression, localization, and interactions in diverse experimental settings. Researchers can effectively investigate VRK1's role in cell signaling pathways and disease mechanisms. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support scientists in advancing their understanding of VRK1's biological significance and potential therapeutic applications.